PortfoliosLab logo
NOVN.SW vs. ^GSPC
Performance
Risk-Adjusted Performance
Drawdowns
Volatility

Correlation

The correlation between NOVN.SW and ^GSPC is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

NOVN.SW vs. ^GSPC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Novartis AG (NOVN.SW) and S&P 500 (^GSPC). The values are adjusted to include any dividend payments, if applicable.

800.00%1,000.00%1,200.00%1,400.00%1,600.00%1,800.00%2,000.00%December2025FebruaryMarchAprilMay
1,936.86%
913.59%
NOVN.SW
^GSPC

Key characteristics

Sharpe Ratio

NOVN.SW:

0.22

^GSPC:

0.48

Sortino Ratio

NOVN.SW:

0.58

^GSPC:

0.80

Omega Ratio

NOVN.SW:

1.09

^GSPC:

1.12

Calmar Ratio

NOVN.SW:

0.43

^GSPC:

0.49

Martin Ratio

NOVN.SW:

1.05

^GSPC:

1.90

Ulcer Index

NOVN.SW:

6.89%

^GSPC:

4.90%

Daily Std Dev

NOVN.SW:

19.88%

^GSPC:

19.37%

Max Drawdown

NOVN.SW:

-42.25%

^GSPC:

-56.78%

Current Drawdown

NOVN.SW:

-8.69%

^GSPC:

-7.82%

Returns By Period

In the year-to-date period, NOVN.SW achieves a 6.39% return, which is significantly higher than ^GSPC's -3.70% return. Over the past 10 years, NOVN.SW has underperformed ^GSPC with an annualized return of 5.51%, while ^GSPC has yielded a comparatively higher 10.43% annualized return.


NOVN.SW

YTD

6.39%

1M

2.79%

6M

1.47%

1Y

4.23%

5Y*

7.25%

10Y*

5.51%

^GSPC

YTD

-3.70%

1M

13.67%

6M

-5.18%

1Y

9.18%

5Y*

14.14%

10Y*

10.43%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

NOVN.SW vs. ^GSPC — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NOVN.SW
The Risk-Adjusted Performance Rank of NOVN.SW is 6262
Overall Rank
The Sharpe Ratio Rank of NOVN.SW is 6060
Sharpe Ratio Rank
The Sortino Ratio Rank of NOVN.SW is 5454
Sortino Ratio Rank
The Omega Ratio Rank of NOVN.SW is 5757
Omega Ratio Rank
The Calmar Ratio Rank of NOVN.SW is 7171
Calmar Ratio Rank
The Martin Ratio Rank of NOVN.SW is 6565
Martin Ratio Rank

^GSPC
The Risk-Adjusted Performance Rank of ^GSPC is 6767
Overall Rank
The Sharpe Ratio Rank of ^GSPC is 6464
Sharpe Ratio Rank
The Sortino Ratio Rank of ^GSPC is 6464
Sortino Ratio Rank
The Omega Ratio Rank of ^GSPC is 6767
Omega Ratio Rank
The Calmar Ratio Rank of ^GSPC is 6969
Calmar Ratio Rank
The Martin Ratio Rank of ^GSPC is 7171
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

NOVN.SW vs. ^GSPC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Novartis AG (NOVN.SW) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current NOVN.SW Sharpe Ratio is 0.22, which is lower than the ^GSPC Sharpe Ratio of 0.48. The chart below compares the historical Sharpe Ratios of NOVN.SW and ^GSPC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.00December2025FebruaryMarchAprilMay
0.61
0.47
NOVN.SW
^GSPC

Drawdowns

NOVN.SW vs. ^GSPC - Drawdown Comparison

The maximum NOVN.SW drawdown since its inception was -42.25%, smaller than the maximum ^GSPC drawdown of -56.78%. Use the drawdown chart below to compare losses from any high point for NOVN.SW and ^GSPC. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%December2025FebruaryMarchAprilMay
-5.95%
-7.82%
NOVN.SW
^GSPC

Volatility

NOVN.SW vs. ^GSPC - Volatility Comparison

Novartis AG (NOVN.SW) has a higher volatility of 11.85% compared to S&P 500 (^GSPC) at 11.21%. This indicates that NOVN.SW's price experiences larger fluctuations and is considered to be riskier than ^GSPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%December2025FebruaryMarchAprilMay
11.85%
11.21%
NOVN.SW
^GSPC